Unique resistance of I/LNJ mice to a retrovirus is due to sustained interferon γ-dependent production of virus-neutralizing antibodies

Journal of Experimental Medicine

Volumn 197, Issue 2, 2003, Pages 233-243

  Purdy, Alexandra ^a   Case, Laure ^a   Duvall, Melody ^a   Overstrom Coleman, Max ^a   Monnier, Nilah ^a   Chervonsky, Alexander ^a   Golovkina, Tatyana ^a  

^a JACKSON LABORATORY   (United States)

Author keywords

IFN ; Infection; Resistance; Retrovirus; Virus neutralizing antibodies

Indexed keywords

GAMMA INTERFERON; NEUTRALIZING ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CROSS REACTION; FEMALE; GENE DELETION; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNE SYSTEM; INFECTION PREVENTION; INTERFERON PRODUCTION; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS INFECTION; VIRUS RESISTANCE;

ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, VIRAL; CROSS REACTIONS; FEMALE; IMMUNOGLOBULIN G; INTERFERON TYPE II; MAMMARY GLANDS, ANIMAL; MAMMARY TUMOR VIRUS, MOUSE; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, KNOCKOUT; MILK; NEUTRALIZATION TESTS; RETROVIRIDAE INFECTIONS; SUPERANTIGENS; TUMOR VIRUS INFECTIONS; VARIATION (GENETICS);

EID: 0037454958     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20021499     Document Type: Article

References (47)

1. Acha Orbea, H., and E. Palmer. 1991. Mls-a retrovirus exploits the immune system, Immunol. Today. 12:356-361.
2. Choi, Y., J.W. Kappler, and P. Marrack. 1991. A superantigen encoded in the open reading frame of the 3′ long terminal repeat of the mouse mammary tumor virus. Nature. 350:203-207.
3. MacDonald, H.R., R. Schneider, R.K. Lees, R.C. Howe, H. Acha Orbea, H. Festenstein, R.M. Zinkernagel, and H. Hengartner. 1988. T-cell receptor V beta use predicts reactivity and tolerance to Mlsa-encoded antigens. Nature. 332:40-45.
4. MacDonald, H.R., A.L. Glasebrook, R. Schneider, R.K. Lees, H. Pircher, T. Pedrazzini, O. Kanagawa, J.F. Nicolas, R.C. Howe, R.M. Zinkernagel, et al. 1989. T-cell reactivity and tolerance to Mlsa-encoded antigens. Immunol. Rev. 107:89-108.
5. Held, W., G. Waanders, A.N. Shakhov, L. Scarpellino, H. Acha-Orbea, and H.R. MacDonald. 1993. Superantigen-induced immune stimulation amplifies mouse mammary tumor virus infection and allows virus transmission. Cell. 74:529-540.
6. Marrack, P., E. Kushnir, and J. Kappler. 1991. A maternally inherited superantigen encoded by mammary tumor virus. Nature. 349:524-526.
7. Peters, G., and C. Dickson. 1987. On the mechanism of carcinogenesis by mouse mammary tumor virus. In Cellular and Molecular Biology of Breast Cancer. D. Medina, W. Kidwell, G. Heppner, and E. Anderson, editors. Plenum Publishing Corp., New York. 307-319.
8. Muhlbock, O., and A. Dux. 1981. Histocompatability genes and mammary cancer. Elsevier/North-Holland Biomedical Press, Amsterdam, Netherlands. 545-573.
9. Dembic, Z., M. Ayane, J. Klein, M. Steinmetz, C.O. Benoist, and D.J. Mathis. 1985. Inbred and wild mice carry identical deletions in their E alpha MHC genes. EMBO J. 4:127-131.
10. Begovich, A.B., T.H. Vu, and P.P. Jones. 1990. Characterization of the molecular defects in the mouse Ebf and Ebq genes. Implication for the origin of MHC polimorphism. J. Immunol. 144:1957-1964.
11. Nandi, S., S. Haslam, and C. Helmich. 1972. Mechanisms of resistance to mammary tumor development in C57BL and I strains of mice. I. Noduligenesis, tumorigenesis, and characteristics of nodules and tumors. J. Natl. Cancer Inst. 48:1005-1012.
12. Pucillo, C., R. Cepeda, and R.J. Hodes. 1993. Expression of a MHC class II transgene determines both superantigenicity and susceptibility to mammary tumor virus infection. J. Exp. Med. 178:1441-1445.
13. Wrona, T., and J.P. Dudley. 1996. Major histocompatibility complex class II I-E-independent transmission of C3H mouse mammary tumor virus. J. Virol. 70:1246-1249.
14. Frankel, W.N., C. Rudy, J.M. Coffin, and B.T. Huber. 1991. Linkage of Mls genes to endogenous mammary tumour viruses of inbred mice. Nature. 349:526-528.
15. Woodland, D.L., M.P. Happ, K.J. Gollob, and E. Palmer. 1991. An endogenous retrovirus mediating deletion of alpha beta T cells? Nature. 349:529-530.
16. Dyson, P.J., A.M. Knight, S. Fairchild, E. Simpson, and K. Tomonari. 1991. Genes encoding ligands for deletion of V beta 11 T cells cosegregate with mammary tumour virus genomes. Nature. 349:531-532.
17. Golovkina, T.V., A.V. Chervonsky, J.P. Dudley, and S.R. Ross. 1992. Transgenic mouse mammary tumor virus superantigen expression prevents viral infection. Cell. 69:637-645.
18. Golovkina, T.V. 2000. A novel mechanism of resistance to mouse mammary tumor virus infection. J. Virol. 74:2752-2759.
19. Dalton, D.K., S. Pitts-Meek, S. Keshav, I.S. Figari, A. Bradley, and T.A. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science. 259:1739-1742.
20. Golovkina, T.V., I. Piazzon, I. Nepomanschy, V. Buggiano, M. de Olano Vela, and S.R. Ross. 1997. Generation of a tumorigenic milk-borne mouse mammary tumor virus by recombination between endogenous and exogenous viruses. J. Virol. 71:3895-3903.
21. Golovkina, T.V., A. Chervonsky, J.C. Prescott, C.A. Janeway, and S.R. Ross. 1994. The mouse mammary tumor virus envelope gene product is required for superantigen presentation to T cells. J. Exp. Med. 179:439-446.
22. Golovkina, T.V., A. Jaffe, and S.R. Ross. 1994. Coexpression of exogenous and endogenous mouse mammary tumor virus RNA in vivo results in viral recombination and broadens the virus host range. J. Virol. 68:5019-5026.
23. Scherer, M.T., L. Ignatowicz, A. Pullen, J. Kappler, and P. Marrack. 1995. The use of mammary tumor virus (Mtv)-negative and single-Mtv mice to evaluate the effects of endogenous viral superantigens on the T cell repertoire. J. Exp. Med. 182:1493-1504.
24. Golovkina, T.V., J.P. Dudley, and S.R. Ross. 1998. B and T cells are required for mouse mammary tumor virus spread within the mammary gland. J. Immunol. 161:2375-2382.
25. Nandi, S., S. Halsam, and C.D. Aldrich. 1971. Antigenically distinct forms of mammary tumor virus in blood and mammary tissues of mice. J. Natl. Cancer Inst. 46:1035-1038.
26. Piazzon, I., A. Goldman, S. Torello, I. Nepomnaschy, A. Deroche, and G. Dran. 1994. Transmission of an Mls-1a-like superantigen to BALB/c mice by foster-nursing on F1 Mls-1bxa mothers. Sex-influenced onset of clonal deletion. J. Immunol. 153:1553-1562.
27. Ignatowicz, L., J. Kappler, and P. Marrack. 1992. The effects of chronic infection with a superantigen-producing virus. J. Exp. Med. 175:917-923.
28. Snapper, C.M., and W.E. Paul. 1987. Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science. 236:944-947.
29. Farrar, M.A., and R.D. Schreiber. 1993. The molecular cell biology of interferon-gamma and its receptor. Annu. Rev. Immunol. 11:571-611.
30. Dalton, D.K., S. Pitts-Meek, S. Keshav, I.S. Figari, A. Bradley, and T.A. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science. 259:1739-1742.
31. Ochsenbein, A.F., and R.M. Zinkernagel. 2000. Natural antibodies and complement link innate and acquired immunity. Immunol. Today. 21:624-630.
32. Miedema, F., L. Meyaard, M. Koot, M.R. Klein, M.T. Roos, M. Groenink, R.A. Fouchier, A.B. Van't Wout, M. Tersmette, P.T. Schellekens, et al. 1994. Changing virus-host interactions in the course of HIV-1 infection. Immunol. Rev. 140:35-72.
33. Altrock, B.W., R.D. Cardiff, and P.B. Blair. 1981. Murine mammary tumor virus seroepidemiology in BALB/cfC3H mice: correlation with tumor development. J. Natl. Cancer Inst. 67:163-168.
34. + T cells are required to stimulate B cells after infection with mouse mammary tumor virus. J. Exp. Med. 177:359-366.
35. Luther, S.A., I. Maillard, F. Luthi, L. Scarpellino, H. Diggelmann, and H. Acha Orbea. 1997. Early neutralizing antibody response against mouse mammary tumor virus: critical role of viral infection and superantigen-reactive T cells. J. Immunol. 159:2807-2814.
36. Janeway, C.A. 1989. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb. Symp. Quant. Biol. 54:1-13.
37. Medzhitov, R., and C.A. Janeway, Jr. 1997. Innate immunity: the virtues of a nonclonal system of recognition. Cell. 91:295-298.
38. Alexopoulou, L., A.C. Holt, R. Medzhitov, and R.A. Flavell. 2001. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature. 413:732-738.
39. Toshchakov, V., B.W. Jones, P.Y. Perera, K. Thomas, M.J. Cody, S. Zhang, B.R. Williams, J. Major, T.A. Hamilton, M.J. Fenton, and S.N. Vogel. 2002. TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages. Nat. Immunol. 3:392-398.
40. Mita, Y., K. Dobashi, Y. Shimizu, T. Nakazawa, and M. Mori. 2001. Toll-like receptor 2 and 4 surface expressions on human monocytes are modulated by interferon-gamma and macrophage colony-stimulating factor. Immunol. Lett. 78:97-101.
41. Billiau, A. 1996. Interferon-gamma: biology and role in pathogenesis. Adv. Immunol. 62:61-130.
42. Yasukawa, H., A. Sasaki, and A. Yoshimura. 2000. Negative regulation of cytokine signaling pathways. Annu. Rev. Immunol. 18:143-164.
43. Chesebro, B., and K. Wehrly. 1979. Identification of a non-H-2 gene (Rfv-3) influencing recovery from viremia and leukemia induced by Friend virus complex. Proc. Natl. Acad. Sci. USA. 76:425-429.
44. Hasenkrug, K.J., A. Valenzuela, V.A. Letts, J. Nishio, B. Chesebro, and W.N. Frankel. 1995. Chromosome mapping of Rfv3, a host resistance gene to Friend murine retrovirus. J. Virol. 69:2617-2620.
45. Super, H.J., K.J. Hasenkrug, S. Simmons, D.M. Brooks, R. Konzek, K.D. Sarge, R.I. Morimoto, N.A. Jenkins, D.J. Gilbert, N.G. Copeland, et al. 1999. Fine mapping of the Friend retrovirus resistance gene, Rfv3, on mouse chromosome 15. J. Virol. 73:7848-7852.
46. Burton, D.R., and D.C. Montefiori. 1997. The antibody response in HIV-1 infection. AIDS. 11 Suppl A:S87-S98.
47. Back, N.K., L. Smit, M. Schutten, P.L. Nara, M. Tersmette, and J. Goudsmit. 1993. Mutations in human immunodeficiency virus type 1 gp41 affect sensitivity to neutralization by gp120 antibodies. J. Virol. 67:6897-6902.